The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 01, 2018
BioSpecifics Technologies announced positive topline data from its Phase 1 trial of Collagenase Clostridium Histolyticum (CCH) for the treatment of ...
read more
The FDA approved Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness (EDS) in pediatric patients (7 to 17 years old...
read more
Taiho Oncology announced the FDA has accepted and granted priority review for the sNDA for Lonsurf.
read more
Thursday, October 25, 2018
The FDA approved Xofluza for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for ...
read more
Wednesday, October 24, 2018
Pfizer and Eli Lilly announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab.
read more
Thursday, October 18, 2018
Proteostasis Therapeutics announced positive preliminary results from three doublet cohorts of the company's ongoing Phase 1 in subjects with cystic ...
read more
Wednesday, October 17, 2018
Eiger announced Phase 2 ULTRA study results in primary and secondary lymphedema of the lower limb demonstrated no improvement of ubenimex over placebo...
read more
Tuesday, October 16, 2018
Cannabics announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (...
read more
SCYNEXIS announced the dosing of the first patient with a Candida auris infection in a Phase 3 open-label study evaluating oral ibrexafungerp in ...
read more
Thursday, October 11, 2018
Boehringer Ingelheim announced the FDA approved new labeling for Stiolto Respimat Inhalation Spray that includes data showing a meaningful reduction ...
read more
Tuesday, October 09, 2018
The IAVI announces the start of a Phase I clinical trial to test a novel vaccine candidate designed to stimulate the immune system to initiate a first...
read more
Rare Disease Therapeutics announced the launch of ANAVIP, an equine-derived antivenin indicated for the management of adult and pediatric patients ...
read more
Allergan announced the initiation of two global clinical research programs for brazikumab, an investigational drug being studied for inflammatory ...
read more
Wednesday, October 03, 2018
Eagle Pharmaceuticals has entered into an agreement with the USAMRICD to conduct a study to evaluate the neuroprotective effects of Ryanodex (...
read more
The FDA approved Arikayce for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex.
read more